Search

everythinglearnresearchcommunity

for

Search:↓

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Different γδ T cell types have unique roles in causing alopecia areata.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Next-generation Treg therapies could help achieve lasting immune tolerance in type 1 diabetes.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Lipid-antigen stimulation may play a role in folliculotropic mycosis fungoides.

Scientists found a new type of skin cell that could help with skin repair and these cells work better with a certain protein.

Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.

Clonally expanded CD8+ T cells cause alopecia areata.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Non-myeloablative stem cell transplants are a promising, less toxic option for older or weaker patients, with fewer side effects and good outcomes.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

Targeting specific T cells may help treat alopecia areata.

Hair follicles produce IL-7, which is essential for certain skin lymphoma cells to survive.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Innate lymphoid cells type 1 may contribute to alopecia areata.

B cells can both help and hinder the body's defense against melanoma.

CD4+ skin cells may be precursors to basal cell carcinoma.

The role of γδT-cells in causing alopecia areata remains unclear.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.